EVMT — Evome Medical Technologies Balance Sheet
0.000.00%
HealthcareSpeculativeMicro Cap
Annual balance sheet for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 February 28th | R2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.3 | 9.19 | 7.57 | 8.06 | 0.919 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.53 | 0.397 | 0 | 6.6 | 7.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11.4 | 9.73 | 13.1 | 20 | 21 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.187 | — | — | 5.4 | 13.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 11.6 | 9.73 | 13.1 | 42.7 | 48.3 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.394 | 0.217 | 6.47 | 23.2 | 37.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.409 | 0.232 | 6.49 | 29.5 | 44.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11.2 | 9.5 | 6.64 | 13.2 | 4 |
| Total Liabilities & Shareholders' Equity | 11.6 | 9.73 | 13.1 | 42.7 | 48.3 |
| Total Common Shares Outstanding |